Premium
Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll‐like 4 receptor signaling
Author(s) -
Nadanaka Satomi,
Hashiguchi Taishi,
Kitagawa Hiroshi
Publication year - 2020
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.201902076r
Subject(s) - inflammation , carcinogenesis , toll like receptor , glycosaminoglycan , microbiology and biotechnology , tumor promotion , cancer research , receptor , biology , immunology , chemistry , cancer , biochemistry , innate immune system , genetics
Certain proteoglycans, consisting of a core protein and glycosaminoglycan (GAG) chains, are among the many types of biomolecules that can function as damage‐associated molecular pattern molecules (DAMPs). We, therefore, hypothesized that the expression level and structural alteration of GAGs affect inflammation. We have previously reported that the effects on GAG biosynthesis caused by loss of the tumor suppressor gene exostosin‐like 2 ( Extl2 ) influence liver injury and regeneration processes. To examine how altered GAG biosynthesis may underscore the relationship between inflammation and tumorigenesis, we assessed its role in non‐alcoholic steatohepatitis and hepatocarcinoma (HCC) induced by dietary obesity and insulin‐resistance. We demonstrated that GAGs produced in the absence of EXTL2 act as DAMPs and directly input signals into cells via the Toll‐like 4 receptor. In addition, the subsequent transcriptional activation of inflammatory and tumor‐promoting cytokines by NF‐κB contributes to injury‐ and inflammation‐driven tumor promotion. Thus, dysregulated biosynthesis of GAGs is considered to increase the risk of HCC in a background of obesity and diabetes.